Preventing brain spread in limited-stage small cell lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two ways to manage limited-stage small cell lung cancer that has improved after initial chemotherapy and radiation. Participants will either get preventive brain radiation or have regular brain MRI scans instead, to see which approach is safer and works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with limited-stage small cell lung cancer confirmed by lab tests (biopsy/samples).
- After first chemotherapy plus radiation, your response is remission (complete or partial) by tumor scan rules.
- You must have a brain MRI within the last 4 weeks that shows no brain or covering-membrane spread.
- You are between 18 and 75 years old and your general health score (ECOG) is 0 to 2.
- Your last cancer treatment must be finished within the past 8 weeks, and you must be expected to live at least 12 weeks.
- Your blood counts, liver, kidneys, and blood clotting tests must meet the study thresholds.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to follow and treat small-cell lung cancer in the brain: preventive brain radiation versus close monitoring with MRI scans and treatment only if needed. It may help people avoid unnecessary brain treatment or choose the safer timing strategy.
This trial is testing a new medication, HS-20093, to see if it can help people with limited-stage small cell lung cancer who have completed chemoradiation but cannot have surgery. The drug is given as an extra treatment after the standard therapy to try to prevent the cancer from coming back.
This trial tests a new drug (adebrelimab) combined with standard chemotherapy and radiation for limited-stage small cell lung cancer. After the initial treatment, the drug is continued to help keep the cancer from coming back.
This study follows patients with small cell lung cancer who receive radiation therapy combined with other treatments. Researchers will track how well the treatment works and how patients respond over time to help improve future care.
This trial combines radiation therapy with chemotherapy and an immunotherapy drug to treat limited-stage small cell lung cancer. The goal is to see if this approach helps people live longer and delays the cancer from coming back.
This trial tests a new radiation approach for people with small cell lung cancer that has spread to the brain. It combines whole-brain radiation that avoids the memory centers, followed by focused radiation to the tumors, while you also receive standard chemotherapy and immunotherapy.
Hear when a new Limited Stage Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.